81 related articles for article (PubMed ID: 6774657)
21. Inhibition of L-dopa-induced growth hormone stimulation by pyridoxine and chlorpromazine.
Mims RB; Scott CL; Modebe O; Bethune JE
J Clin Endocrinol Metab; 1975 Feb; 40(2):256-9. PubMed ID: 1117978
[TBL] [Abstract][Full Text] [Related]
22. Measurement of pituitary hormones: clinical applications. 5. Prolactin.
Donald RA; Espiner EA; Hodgkinson SC; Evans K
N Z Med J; 1976 Jun; 83(566):431-5. PubMed ID: 9604
[TBL] [Abstract][Full Text] [Related]
23. Dissociation of prolactin responsiveness to TRH and chlorpromazine in women with isolated gonadotropin deficiency.
Spitz IM; Almaliach U; Rosen E; Polishuk W; Rabinowitz D
J Clin Endocrinol Metab; 1977 Dec; 45(6):1173-8. PubMed ID: 412859
[TBL] [Abstract][Full Text] [Related]
24. Abnormalities in the regulation of prolactin in patients with chronic renal failure.
Ramirez G; O'Neill WM; Bloomer HA; Jubiz W
J Clin Endocrinol Metab; 1977 Oct; 45(4):658-61. PubMed ID: 410821
[TBL] [Abstract][Full Text] [Related]
25. Suppression of thyrotropin (TSH) and prolactin (PRL) release by pyridoxine in chronic primary hypothyroidism.
Delitala G; Rovasio P; Lotti G
J Clin Endocrinol Metab; 1977 Nov; 45(5):1019-22. PubMed ID: 925127
[TBL] [Abstract][Full Text] [Related]
26. Thyroid hormone inhibition of the prolactin response to thyrotropin-releasing hormone.
Snyder PJ; Jacobs LS; Utiger RD; Daughaday WH
J Clin Invest; 1973 Sep; 52(9):2324-9. PubMed ID: 4199418
[TBL] [Abstract][Full Text] [Related]
27. Effect of ghrelin and thyrotropin-releasing hormone on prolactin secretion in normal women.
Messini CI; Dafopoulos K; Chalvatzas N; Georgoulias P; Anifandis G; Messinis IE
Horm Metab Res; 2010 Mar; 42(3):204-8. PubMed ID: 19844859
[TBL] [Abstract][Full Text] [Related]
28. Dynamic evaluation of prolactin secretion in patients with oligospermia: effects of treatment with metergoline.
Masala A; Delitala G; Alagna S; Devilla L; Rovasio PP; Lotti G
Fertil Steril; 1979 Jan; 31(1):63-7. PubMed ID: 105938
[TBL] [Abstract][Full Text] [Related]
29. [Dynamics of prolactin in human blood].
Inoue K; Irie M
Horumon To Rinsho; 1974 Mar; 22(3):358-72. PubMed ID: 4210031
[No Abstract] [Full Text] [Related]
30. Stimulation of human prolactin secretion by sulpiride.
Kato Y; Ohgo S; Chihara K; Imura H
Endocrinol Jpn; 1975 Oct; 22(5):457-60. PubMed ID: 813995
[TBL] [Abstract][Full Text] [Related]
31. Compensatory increase in TSH secretion without effect on prolactin secretion in patients treated with aminoglutethimide.
Santen RJ; Wells SA; Cohn N; Demers LM; Misbin RI; Foltz EL
J Clin Endocrinol Metab; 1977 Oct; 45(4):739-46. PubMed ID: 410823
[No Abstract] [Full Text] [Related]
32. Growth rate and secretion of pituitary hormones in relation to age and chronic treatment with thyrotropin-releasing hormone in prepubertal dairy heifers.
Davis SL; Sasser RG; Thacker DL; Ross RH
Endocrinology; 1977 May; 100(5):1394-402. PubMed ID: 191244
[TBL] [Abstract][Full Text] [Related]
33. Effect of pyridoxine on human hypophyseal trophic hormone release: a possible stimulation of hypothalamic dopaminergic pathway.
Delitala G; Masala A; Alagna S; Devilla L
J Clin Endocrinol Metab; 1976 Mar; 42(3):603-6. PubMed ID: 1254699
[TBL] [Abstract][Full Text] [Related]
34. Stimulating and inhibiting effects of thyrotropin-releasing hormone on growth hormone release in rats.
Chihara K; Kato Y; Ohgo S; Iwasaki Y; Abe H; Maeda K; Imura H
Endocrinology; 1976 Apr; 98(4):1047-53. PubMed ID: 819245
[TBL] [Abstract][Full Text] [Related]
35. Secondary hypopituitarism: evidence for continuing regulation of hormone release.
Woolf PD; Jacobs LS; Donofrio R; Burday SZ; Schalch DS
J Clin Endocrinol Metab; 1974 Jan; 38(1):71-6. PubMed ID: 4203527
[No Abstract] [Full Text] [Related]
36. Characteristics of prolactin-releasing response to salsolinol (SAL) and thyrotropin-releasing hormone (TRH) in ruminants.
Hashizume T; Onodera Y; Shida R; Isobe E; Suzuki S; Sawai K; Kasuya E; Nagy GM
Domest Anim Endocrinol; 2009 Feb; 36(2):99-104. PubMed ID: 19070987
[TBL] [Abstract][Full Text] [Related]
37. Abnormal prolactin response to thyrotrophic releasing hormone in essential hypertension.
Hauger-Klevene JH; Pinkas MB
Int J Clin Pharmacol Res; 1983; 3(2):111-4. PubMed ID: 6434439
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic value of thyrotropin-releasing-hormone stimulation in patients with pituitary tumor.
Cook DM; Greer MA; Paxton H
West J Med; 1987 Aug; 147(2):161-4. PubMed ID: 3116772
[TBL] [Abstract][Full Text] [Related]
39. Submaximal plasma prolactin response to TRH and dopamine activity in man.
Spoov J
Pharmacopsychiatry; 1985 Nov; 18(6):330-2. PubMed ID: 3003766
[TBL] [Abstract][Full Text] [Related]
40. Apomorpine inhibits the prolactin but not the TSH response to thyrotropin releasing hormone.
Cooper DS; Jacobs LS
J Clin Endocrinol Metab; 1977 Feb; 44(2):404-7. PubMed ID: 402381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
